Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy

被引:23
作者
Jayasankar, V
Pirolli, TJ
Bish, LT
Berry, MF
Burdick, J
Grand, T
Woo, YJ
机构
[1] Univ Penn, Sch Med, Div Cardiothorac Surg, Dept Surg, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA
关键词
gene therapy; heart failure; remodeling; growth factors;
D O I
10.1016/j.yjmcc.2004.01.010
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. - Post-infarction heart failure is characterized by progressive left ventricular dilatation and wall thinning, with both systolic and diastolic cardiac dysfunction. Human growth hormone (GH) stimulates cardiac hypertrophy when secreted in excess and directly enhances cardiomyocyte contractile function. We hypothesized that local myocardial overexpression of GH could prevent ventricular remodeling and heart failure following myocardial infarction (MI) in rats. Methods and Results. - Rats underwent ligation of the left anterior descending coronary artery with direct intramyocardial injection of adenovirus encoding human GH (n = 8) or null virus as control (n = 8). Six weeks following MI, Adeno-GH treated animals had significant preservation of both systolic and diastolic cardiac function compared to Null animals (maximum dP/dt GH 2927 83 vs Null 1622 159 mmHg/sec, p < 0.001; minimum dP/dt -2409 +/- 82 vs -1195 +/- 179 mmHg/sec, p < 0.01). GH animals had improved ventricular geometry with decreased chamber dilatation (13.2 +/- 0.13 vs 14.4 +/- 0.15 mm, p < 0.001) and increased wall thickness (2.02 +/- 0.10 vs 1.28 +/- 0.07 mm, p < 0.001), and this was associated with advantageous myocardial hypertrophy with increased cardiomyocyte fiber size. Local myocardial overexpression of GH protein was seen in Adeno-GH animals, while serum levels of human GH were undetectable after 6 weeks. Conclusions. - Treatment with Adeno-GH following MI resulted in reduced ventricular dilatation, increased local myocardial hypertrophy, and preservation of both systolic and diastolic cardiac function. No significant systemic exposure to growth hormone transgene was observed. The induction of regional hypertrophy is a novel approach to treating heart failure, and may be useful to treat or prevent post-infarction ischemic cardiomyopathy. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:531 / 538
页数:8
相关论文
共 37 条
[1]
ADAMAFIO NA, 1991, GROWTH REGULAT, V1, P17
[2]
GROWTH-HORMONE RAPIDLY ACTIVATES INSULIN-LIKE GROWTH FACTOR-I GENE-TRANSCRIPTION INVIVO [J].
BICHELL, DP ;
KIKUCHI, K ;
ROTWEIN, P .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (11) :1899-1908
[3]
CAIDAHL K, 1994, CLIN ENDOCRINOL, V40, P393
[4]
Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat - A combined in vivo and in vitro evaluation [J].
Cittadini, A ;
Stromer, H ;
Katz, SE ;
Clark, R ;
Moses, AC ;
Morgan, JP ;
Douglas, PS .
CIRCULATION, 1996, 93 (04) :800-809
[5]
Growth hormone prolongs survival in experimental postinfarction heart failure [J].
Cittadini, A ;
Isgaard, J ;
Monti, MG ;
Casaburi, C ;
Di Gianni, A ;
Serpico, R ;
Iaccarino, G ;
Saccà, L .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (12) :2154-2163
[6]
INDUCTION OF MYOCARDIAL INSULIN-LIKE GROWTH FACTOR-I GENE-EXPRESSION IN LEFT-VENTRICULAR HYPERTROPHY [J].
DONOHUE, TJ ;
DWORKIN, LD ;
LANGO, MN ;
FLIEGNER, K ;
LANGO, RP ;
BENSTEIN, JA ;
SLATER, WR ;
CATANESE, VM .
CIRCULATION, 1994, 89 (02) :799-809
[7]
A preliminary study of growth hormone in the treatment of dilated cardiomyopathy [J].
Fazio, S ;
Sabatini, D ;
Capaldo, B ;
Vigorito, C ;
Giordano, A ;
Guida, R ;
Pardo, F ;
Biondi, B ;
Sacca, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (13) :809-814
[8]
Growth hormone and insulin-like growth factor-1 in acute myocardial infarction [J].
Friberg, L ;
Werner, S ;
Eggertsen, G ;
Ahnve, S .
EUROPEAN HEART JOURNAL, 2000, 21 (18) :1547-1554
[9]
FROESCH ER, 1985, ANNU REV PHYSIOL, V47, P443
[10]
Clinical features and therapeutic outcomes of 65 patients with acromegaly at Tokyo Women's Medical University [J].
Fukuda, I ;
Hizuka, N ;
Murakami, Y ;
Itoh, E ;
Yasumoto, K ;
Sata, A ;
Takano, K .
INTERNAL MEDICINE, 2001, 40 (10) :987-992